Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Mar. 19, 2019– Urovant Sci...
read more
Government announces ‘appalling’ 5% price hike of NHS dental treatment

Government announces ‘appalling’ 5% price hike of NHS dental treatment

Government announces ‘appalling’ price...
read more